SIWA Therapeutics To Participate in September Investor Conferences

SIWA Therapeutics, Inc., a pre-clinical stage biopharmaceutical company focused on aggressive cancers and other life-threatening diseases that should be eligible for FDA fast-tracking, will participate in two September virtual conferences. Lewis Gruber, CEO and CSO of SIWA, will attend Biopharm America 2020 , which will take place virtually from September 21-24. Gruber also will attend the O